(Q50431396)

English

Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults: preliminary results from the prospective, multicenter study NPC-2003-GPOH/DCOG.

scientific article published on 22 February 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/22359313

Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults: preliminary results from the prospective, multicenter study NPC-2003-GPOH/DCOG. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/22359313

Christian Michel Zwaan

2

object named as

Christian Michel Zwaan

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/22359313

author name string

Martina Buehrlen

1

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/22359313

Bernd Granzen

3

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/22359313

Lisa Lassay

4

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/22359313

Peter Deutz

5

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/22359313

Peter Vorwerk

6

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/22359313

Gundula Staatz

7

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/22359313

Günther Gademann

8

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/22359313

Hans Christiansen

9

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/22359313

Foppe Oldenburger

10

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/22359313

Miriam Tamm

11

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/22359313

Rolf Mertens

12

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/22359313

language of work or name

0 references

publication date

22 February 2012

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/22359313

number of pages

9

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/22359313

118

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/22359313

19

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/22359313

4892-4900

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/22359313

Nasopharyngeal carcinoma in adolescents: a retrospective review of 42 patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

21 January 2018

Nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

21 January 2018

Childhood nasopharyngeal carcinoma: from biology to treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

21 January 2018

Epstein-barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

21 January 2018

Treatment outcome after radiotherapy alone for patients with Stage I-II nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

21 January 2018

Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

21 January 2018

Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

21 January 2018

Treatment approaches to nasopharyngeal carcinoma: a review.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

21 January 2018

Prognostic factors and long-term outcomes of childhood nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

21 January 2018

Treatment of nasopharyngeal carcinoma in children and adolescents: definitive results of a multicenter study (NPC-91-GPOH).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

21 January 2018

Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

21 January 2018

The efficiency of different chemoradiotherapy regimens in patients with paediatric nasopharynx cancer: review of 46 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

21 January 2018

Nasopharyngeal carcinoma in young patients: a systematic review of racial demographics

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

21 January 2018

Pediatric nasopharyngeal carcinoma: Anatomoclinic aspects, therapeutic results and evolutive particularities

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

21 January 2018

Nasopharyngeal carcinoma in the pediatric age group: the northern Israel (Rambam) medical center experience, 1989-2004.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

21 January 2018

Radiation and chemotherapy combination for nasopharyngeal carcinoma in children: Radiotherapy dose adaptation after chemotherapy response to minimize late effects

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

21 January 2018

Long-term treatment results for nasopharyngeal carcinoma: the Sahlgrenska University Hospital experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

21 January 2018

Pediatric and young adult nasopharyngeal carcinoma patients treated with preradiation Cisplatin and docetaxel chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

21 January 2018

Nasopharyngeal carcinoma: relationship between 18F-FDG PET-CT maximum standardized uptake value, metabolic tumour volume and total lesion glycolysis and TNM classification

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

21 January 2018

Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in patients with carcinoma of the nasopharynx: diagnostic accuracy and impact on clinical management.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

21 January 2018

Comprehensive imaging of residual/ recurrent nasopharyngeal carcinoma using whole-body MRI at 3 T compared with FDG-PET-CT.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

21 January 2018

Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

21 January 2018

Nasopharyngeal carcinoma in adults: treatment results after long-term follow-up with special reference to adjuvant interferon-beta in undifferentiated carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

21 January 2018

Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

21 January 2018

Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

21 January 2018

Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

21 January 2018

Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

21 January 2018

Treatment of nasopharyngeal carcinoma with Epstein-Barr virus--specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

21 January 2018

Whole-tumor-antigen-pulsed dendritic cells elicit cytotoxic T-cell response against pediatric nasopharyngeal carcinoma in vitro

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

21 January 2018

Nasopharyngeal carcinoma in children: comparison of conventional and intensity-modulated radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

7 January 2021

based on heuristic

inferred from DOI database lookup

Carcinoma of the nasopharynx in young patients: a single institution experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful treatment of nasopharyngeal carcinoma with interferon

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

7 January 2021

based on heuristic

inferred from DOI database lookup

Advances in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

7 January 2021

based on heuristic

inferred from DOI database lookup

Nasopharyngeal carcinoma treated by radical radiotherapy alone: Ten-year experience of a single institution

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27395

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.27395

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/22359313

release_lldp326fxzdsriavvflrkvh55q

1 reference

https://api.fatcat.wiki/v0/release/lldp326fxzdsriavvflrkvh55q

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 March 2018

http://europepmc.org/abstract/MED/22359313

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50431396&oldid=2003613571"